Global Sulfonamides Market Growth (Status and Outlook) 2025-2031

September 2025 | 99 pages | ID: G31A6E195F4EN
LP Information

Abstracts

According to this study, the global Sulfonamides market size will reach US$ million by 2031.

Sulfonamides (sulphonamides) is a man-made group of medicines that includes the sulfonamide chemical group. Which is also called sulfa drugs. Sulfonamide antimicrobials are bacteriostatic (helps to stop generating new bacteria, but don’t surely kill them) and also work by intervening with the fusion of folic acid in bacteria, which is important for the formation of nucleic acid and ultimately for DNA and RNA. Sulfonamides are generally used in the pharmaceutical industry at a high rate. Where it is used as bacteriostatic agents which helps to kill the bacteria from human as well as from the animal’s body. Sulfonamides can be prepared in many ways in the laboratory. Sulfonamides are generally used for diabetes, fluid retention, high blood pressure, crohn’s disease, etc.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Sulfonamides Industry Forecast” looks at past sales and reviews total world Sulfonamides sales in 2024, providing a comprehensive analysis by region and market sector of projected Sulfonamides sales for 2025 through 2031. With Sulfonamides sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sulfonamides industry.

This Insight Report provides a comprehensive analysis of the global Sulfonamides landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sulfonamides portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sulfonamides market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sulfonamides and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sulfonamides.

This report presents a comprehensive overview, market shares, and growth opportunities of Sulfonamides market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Intestinal Absorption
• Intestinal Tract Difficult to Absorb
• External Use

Segmentation by Application:

• Systemic Infection
• Intestinal Infection
• Burn Infection
• Other Infections

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Pfizer
• Sanofi
• Roche
• Mylan
• Teva
• Bayer
• Abbott
• GlaxoSmithKline
• Boehringer Ingelheim

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Sulfonamides Market Size (2020-2031)
  2.1.2 Sulfonamides Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Sulfonamides by Country/Region (2020, 2024 & 2031)
2.2 Sulfonamides Segment by Type
  2.2.1 Intestinal Absorption
  2.2.2 Intestinal Tract Difficult to Absorb
  2.2.3 External Use
2.3 Sulfonamides Market Size by Type
  2.3.1 Sulfonamides Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Sulfonamides Market Size Market Share by Type (2020-2025)
2.4 Sulfonamides Segment by Application
  2.4.1 Systemic Infection
  2.4.2 Intestinal Infection
  2.4.3 Burn Infection
  2.4.4 Other Infections
2.5 Sulfonamides Market Size by Application
  2.5.1 Sulfonamides Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Sulfonamides Market Size Market Share by Application (2020-2025)

3 SULFONAMIDES MARKET SIZE BY PLAYER

3.1 Sulfonamides Market Size Market Share by Player
  3.1.1 Global Sulfonamides Revenue by Player (2020-2025)
  3.1.2 Global Sulfonamides Revenue Market Share by Player (2020-2025)
3.2 Global Sulfonamides Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 SULFONAMIDES BY REGION

4.1 Sulfonamides Market Size by Region (2020-2025)
4.2 Global Sulfonamides Annual Revenue by Country/Region (2020-2025)
4.3 Americas Sulfonamides Market Size Growth (2020-2025)
4.4 APAC Sulfonamides Market Size Growth (2020-2025)
4.5 Europe Sulfonamides Market Size Growth (2020-2025)
4.6 Middle East & Africa Sulfonamides Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Sulfonamides Market Size by Country (2020-2025)
5.2 Americas Sulfonamides Market Size by Type (2020-2025)
5.3 Americas Sulfonamides Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Sulfonamides Market Size by Region (2020-2025)
6.2 APAC Sulfonamides Market Size by Type (2020-2025)
6.3 APAC Sulfonamides Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Sulfonamides Market Size by Country (2020-2025)
7.2 Europe Sulfonamides Market Size by Type (2020-2025)
7.3 Europe Sulfonamides Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Sulfonamides by Region (2020-2025)
8.2 Middle East & Africa Sulfonamides Market Size by Type (2020-2025)
8.3 Middle East & Africa Sulfonamides Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL SULFONAMIDES MARKET FORECAST

10.1 Global Sulfonamides Forecast by Region (2026-2031)
  10.1.1 Global Sulfonamides Forecast by Region (2026-2031)
  10.1.2 Americas Sulfonamides Forecast
  10.1.3 APAC Sulfonamides Forecast
  10.1.4 Europe Sulfonamides Forecast
  10.1.5 Middle East & Africa Sulfonamides Forecast
10.2 Americas Sulfonamides Forecast by Country (2026-2031)
  10.2.1 United States Market Sulfonamides Forecast
  10.2.2 Canada Market Sulfonamides Forecast
  10.2.3 Mexico Market Sulfonamides Forecast
  10.2.4 Brazil Market Sulfonamides Forecast
10.3 APAC Sulfonamides Forecast by Region (2026-2031)
  10.3.1 China Sulfonamides Market Forecast
  10.3.2 Japan Market Sulfonamides Forecast
  10.3.3 Korea Market Sulfonamides Forecast
  10.3.4 Southeast Asia Market Sulfonamides Forecast
  10.3.5 India Market Sulfonamides Forecast
  10.3.6 Australia Market Sulfonamides Forecast
10.4 Europe Sulfonamides Forecast by Country (2026-2031)
  10.4.1 Germany Market Sulfonamides Forecast
  10.4.2 France Market Sulfonamides Forecast
  10.4.3 UK Market Sulfonamides Forecast
  10.4.4 Italy Market Sulfonamides Forecast
  10.4.5 Russia Market Sulfonamides Forecast
10.5 Middle East & Africa Sulfonamides Forecast by Region (2026-2031)
  10.5.1 Egypt Market Sulfonamides Forecast
  10.5.2 South Africa Market Sulfonamides Forecast
  10.5.3 Israel Market Sulfonamides Forecast
  10.5.4 Turkey Market Sulfonamides Forecast
10.6 Global Sulfonamides Forecast by Type (2026-2031)
10.7 Global Sulfonamides Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Sulfonamides Forecast

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Sulfonamides Product Offered
  11.1.3 Pfizer Sulfonamides Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 Sanofi
  11.2.1 Sanofi Company Information
  11.2.2 Sanofi Sulfonamides Product Offered
  11.2.3 Sanofi Sulfonamides Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Sanofi Main Business Overview
  11.2.5 Sanofi Latest Developments
11.3 Roche
  11.3.1 Roche Company Information
  11.3.2 Roche Sulfonamides Product Offered
  11.3.3 Roche Sulfonamides Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Roche Main Business Overview
  11.3.5 Roche Latest Developments
11.4 Mylan
  11.4.1 Mylan Company Information
  11.4.2 Mylan Sulfonamides Product Offered
  11.4.3 Mylan Sulfonamides Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Mylan Main Business Overview
  11.4.5 Mylan Latest Developments
11.5 Teva
  11.5.1 Teva Company Information
  11.5.2 Teva Sulfonamides Product Offered
  11.5.3 Teva Sulfonamides Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Teva Main Business Overview
  11.5.5 Teva Latest Developments
11.6 Bayer
  11.6.1 Bayer Company Information
  11.6.2 Bayer Sulfonamides Product Offered
  11.6.3 Bayer Sulfonamides Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Bayer Main Business Overview
  11.6.5 Bayer Latest Developments
11.7 Abbott
  11.7.1 Abbott Company Information
  11.7.2 Abbott Sulfonamides Product Offered
  11.7.3 Abbott Sulfonamides Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Abbott Main Business Overview
  11.7.5 Abbott Latest Developments
11.8 GlaxoSmithKline
  11.8.1 GlaxoSmithKline Company Information
  11.8.2 GlaxoSmithKline Sulfonamides Product Offered
  11.8.3 GlaxoSmithKline Sulfonamides Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 GlaxoSmithKline Main Business Overview
  11.8.5 GlaxoSmithKline Latest Developments
11.9 Boehringer Ingelheim
  11.9.1 Boehringer Ingelheim Company Information
  11.9.2 Boehringer Ingelheim Sulfonamides Product Offered
  11.9.3 Boehringer Ingelheim Sulfonamides Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Boehringer Ingelheim Main Business Overview
  11.9.5 Boehringer Ingelheim Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Sulfonamides Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Sulfonamides Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Intestinal Absorption
Table 4. Major Players of Intestinal Tract Difficult to Absorb
Table 5. Major Players of External Use
Table 6. Sulfonamides Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Sulfonamides Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Sulfonamides Market Size Market Share by Type (2020-2025)
Table 9. Sulfonamides Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Sulfonamides Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Sulfonamides Market Size Market Share by Application (2020-2025)
Table 12. Global Sulfonamides Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Sulfonamides Revenue Market Share by Player (2020-2025)
Table 14. Sulfonamides Key Players Head office and Products Offered
Table 15. Sulfonamides Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Sulfonamides Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Sulfonamides Market Size Market Share by Region (2020-2025)
Table 20. Global Sulfonamides Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Sulfonamides Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Sulfonamides Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Sulfonamides Market Size Market Share by Country (2020-2025)
Table 24. Americas Sulfonamides Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Sulfonamides Market Size Market Share by Type (2020-2025)
Table 26. Americas Sulfonamides Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Sulfonamides Market Size Market Share by Application (2020-2025)
Table 28. APAC Sulfonamides Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Sulfonamides Market Size Market Share by Region (2020-2025)
Table 30. APAC Sulfonamides Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Sulfonamides Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Sulfonamides Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Sulfonamides Market Size Market Share by Country (2020-2025)
Table 34. Europe Sulfonamides Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Sulfonamides Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Sulfonamides Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Sulfonamides Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Sulfonamides Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Sulfonamides
Table 40. Key Market Challenges & Risks of Sulfonamides
Table 41. Key Industry Trends of Sulfonamides
Table 42. Global Sulfonamides Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Sulfonamides Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Sulfonamides Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Sulfonamides Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Pfizer Details, Company Type, Sulfonamides Area Served and Its Competitors
Table 47. Pfizer Sulfonamides Product Offered
Table 48. Pfizer Sulfonamides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Pfizer Main Business
Table 50. Pfizer Latest Developments
Table 51. Sanofi Details, Company Type, Sulfonamides Area Served and Its Competitors
Table 52. Sanofi Sulfonamides Product Offered
Table 53. Sanofi Sulfonamides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Sanofi Main Business
Table 55. Sanofi Latest Developments
Table 56. Roche Details, Company Type, Sulfonamides Area Served and Its Competitors
Table 57. Roche Sulfonamides Product Offered
Table 58. Roche Sulfonamides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Roche Main Business
Table 60. Roche Latest Developments
Table 61. Mylan Details, Company Type, Sulfonamides Area Served and Its Competitors
Table 62. Mylan Sulfonamides Product Offered
Table 63. Mylan Sulfonamides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Mylan Main Business
Table 65. Mylan Latest Developments
Table 66. Teva Details, Company Type, Sulfonamides Area Served and Its Competitors
Table 67. Teva Sulfonamides Product Offered
Table 68. Teva Sulfonamides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Teva Main Business
Table 70. Teva Latest Developments
Table 71. Bayer Details, Company Type, Sulfonamides Area Served and Its Competitors
Table 72. Bayer Sulfonamides Product Offered
Table 73. Bayer Sulfonamides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Bayer Main Business
Table 75. Bayer Latest Developments
Table 76. Abbott Details, Company Type, Sulfonamides Area Served and Its Competitors
Table 77. Abbott Sulfonamides Product Offered
Table 78. Abbott Sulfonamides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Abbott Main Business
Table 80. Abbott Latest Developments
Table 81. GlaxoSmithKline Details, Company Type, Sulfonamides Area Served and Its Competitors
Table 82. GlaxoSmithKline Sulfonamides Product Offered
Table 83. GlaxoSmithKline Sulfonamides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. GlaxoSmithKline Main Business
Table 85. GlaxoSmithKline Latest Developments
Table 86. Boehringer Ingelheim Details, Company Type, Sulfonamides Area Served and Its Competitors
Table 87. Boehringer Ingelheim Sulfonamides Product Offered
Table 88. Boehringer Ingelheim Sulfonamides Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Boehringer Ingelheim Main Business
Table 90. Boehringer Ingelheim Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Sulfonamides Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sulfonamides Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Sulfonamides Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Sulfonamides Sales Market Share by Country/Region (2024)
Figure 8. Sulfonamides Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Sulfonamides Market Size Market Share by Type in 2024
Figure 10. Sulfonamides in Systemic Infection
Figure 11. Global Sulfonamides Market: Systemic Infection (2020-2025) & ($ millions)
Figure 12. Sulfonamides in Intestinal Infection
Figure 13. Global Sulfonamides Market: Intestinal Infection (2020-2025) & ($ millions)
Figure 14. Sulfonamides in Burn Infection
Figure 15. Global Sulfonamides Market: Burn Infection (2020-2025) & ($ millions)
Figure 16. Sulfonamides in Other Infections
Figure 17. Global Sulfonamides Market: Other Infections (2020-2025) & ($ millions)
Figure 18. Global Sulfonamides Market Size Market Share by Application in 2024
Figure 19. Global Sulfonamides Revenue Market Share by Player in 2024
Figure 20. Global Sulfonamides Market Size Market Share by Region (2020-2025)
Figure 21. Americas Sulfonamides Market Size 2020-2025 ($ millions)
Figure 22. APAC Sulfonamides Market Size 2020-2025 ($ millions)
Figure 23. Europe Sulfonamides Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Sulfonamides Market Size 2020-2025 ($ millions)
Figure 25. Americas Sulfonamides Value Market Share by Country in 2024
Figure 26. United States Sulfonamides Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Sulfonamides Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Sulfonamides Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Sulfonamides Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Sulfonamides Market Size Market Share by Region in 2024
Figure 31. APAC Sulfonamides Market Size Market Share by Type (2020-2025)
Figure 32. APAC Sulfonamides Market Size Market Share by Application (2020-2025)
Figure 33. China Sulfonamides Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Sulfonamides Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Sulfonamides Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Sulfonamides Market Size Growth 2020-2025 ($ millions)
Figure 37. India Sulfonamides Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Sulfonamides Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Sulfonamides Market Size Market Share by Country in 2024
Figure 40. Europe Sulfonamides Market Size Market Share by Type (2020-2025)
Figure 41. Europe Sulfonamides Market Size Market Share by Application (2020-2025)
Figure 42. Germany Sulfonamides Market Size Growth 2020-2025 ($ millions)
Figure 43. France Sulfonamides Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Sulfonamides Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Sulfonamides Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Sulfonamides Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Sulfonamides Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Sulfonamides Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Sulfonamides Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Sulfonamides Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Sulfonamides Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Sulfonamides Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Sulfonamides Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Sulfonamides Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Sulfonamides Market Size 2026-2031 ($ millions)
Figure 56. APAC Sulfonamides Market Size 2026-2031 ($ millions)
Figure 57. Europe Sulfonamides Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Sulfonamides Market Size 2026-2031 ($ millions)
Figure 59. United States Sulfonamides Market Size 2026-2031 ($ millions)
Figure 60. Canada Sulfonamides Market Size 2026-2031 ($ millions)
Figure 61. Mexico Sulfonamides Market Size 2026-2031 ($ millions)
Figure 62. Brazil Sulfonamides Market Size 2026-2031 ($ millions)
Figure 63. China Sulfonamides Market Size 2026-2031 ($ millions)
Figure 64. Japan Sulfonamides Market Size 2026-2031 ($ millions)
Figure 65. Korea Sulfonamides Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Sulfonamides Market Size 2026-2031 ($ millions)
Figure 67. India Sulfonamides Market Size 2026-2031 ($ millions)
Figure 68. Australia Sulfonamides Market Size 2026-2031 ($ millions)
Figure 69. Germany Sulfonamides Market Size 2026-2031 ($ millions)
Figure 70. France Sulfonamides Market Size 2026-2031 ($ millions)
Figure 71. UK Sulfonamides Market Size 2026-2031 ($ millions)
Figure 72. Italy Sulfonamides Market Size 2026-2031 ($ millions)
Figure 73. Russia Sulfonamides Market Size 2026-2031 ($ millions)
Figure 74. Egypt Sulfonamides Market Size 2026-2031 ($ millions)
Figure 75. South Africa Sulfonamides Market Size 2026-2031 ($ millions)
Figure 76. Israel Sulfonamides Market Size 2026-2031 ($ millions)
Figure 77. Turkey Sulfonamides Market Size 2026-2031 ($ millions)
Figure 78. Global Sulfonamides Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Sulfonamides Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Sulfonamides Market Size 2026-2031 ($ millions)